General MedicationsORALStandard
NEREUS
TRADIPITANT
Standard Dose
85MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview NEREUS is listed in Drugs@FDA under application 220152 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient TRADIPITANT Form and strength CAPSULE;ORAL - 85MG Sponsor VANDA PHARMS INC Submission history Latest submission status date: 2025-12-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview NEREUS is listed in Drugs@FDA under application 220152 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TRADIPITANT Form and strength CAPSULE;ORAL - 85MG Sponsor VANDA PHARMS INC Submission history Latest submission status date: 2025-12-30 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.